DOTS Strategy for Tuberculosis in Samara, Russia
Author Information
Author(s): Y Balabanova, F Drobniewski, I Fedorin, S Zakharova, V Nikolayevskyy, R Atun, R Coker
Primary Institution: HPA Mycobacterium Reference Unit, Clinical TB and HIV Group, St Bartholomew and Queen Mary School of Medicine
Hypothesis
Can the DOTS program improve tuberculosis treatment outcomes in Samara, Russia?
Conclusion
The implementation of DOTS in Samara, Russia, was feasible and successful, but drug-resistant tuberculosis rates were high.
Supporting Evidence
- 75.3% of patients were successfully treated under the DOTS program.
- 24.9% of new cases were isoniazid resistant.
- Drug resistance was strongly associated with infection from the Beijing strain.
Takeaway
This study shows that a new treatment program helped many people with tuberculosis in Russia, but some still had tough-to-treat infections.
Methodology
A prospective study was conducted to implement the DOTS program and analyze treatment outcomes.
Potential Biases
Potential bias due to the transfer of patients to individualized treatment regimens.
Limitations
The study was limited to patients recruited until the third quarter of 2003, and outcomes for later patients were recorded under a different system.
Participant Demographics
The mean age of participants was 38.5 years, with 80.2% being men and 19.8% women; 30.5% were prisoners.
Statistical Information
Confidence Interval
95% CI 37.9–39.1 years
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website